Lake City Medical Center | |
340 Nw Commerce Dr, Lake City, Florida 32055 | |
(386) 719-9000 | |
Name | Lake City Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 340 Nw Commerce Dr, Lake City, Florida |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 100156 |
NPI Number | 1992751879 |
Organization Name | NOTAMI HOSPITALS OF FLORIDA INC |
Doing Business As | HCA FLORIDA LAKE CITY HOSPITAL |
Address | 340 Nw Commerce Dr, Lake City, FL 32055 |
Hospital Type | General Acute Care Hospital |
Phone Number | 386-719-9000 |
News Archive
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
The Duke-Margolis Center for Health Policy and West Health have issued two strategic roadmaps with recommendations for advancing value-based payment (VBP) reform in the U.S. healthcare system.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
The holidays are upon us, and as families visit Grandma and Grandpa's and other homes that may not be used to having little ones underfoot, it's an important reminder to safely store dangerous products.
› Verified 8 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
The Duke-Margolis Center for Health Policy and West Health have issued two strategic roadmaps with recommendations for advancing value-based payment (VBP) reform in the U.S. healthcare system.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
The holidays are upon us, and as families visit Grandma and Grandpa's and other homes that may not be used to having little ones underfoot, it's an important reminder to safely store dangerous products.
› Verified 8 days ago
Shands Lake Shore Regional Medical Center Acute Care Hospital Location: 368 Ne Franklin St, Lake City, Florida 32055 Phone: (386) 292-8000 | |
Lake City Medical Center Acute Care Hospital Location: 340 Nw Commerce Dr, Lake City, Florida 32055 Phone: (386) 719-9000 |